Predictors of drug survival of biologic therapies in psoriasis patients (vol 45, pg 813, 2020)

2024-07-052024-07-052020-08-310954-6634https://doi.org/10.1080/09546634.2020.1816609https://hdl.handle.net/11452/42998eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineDermatologyPredictors of drug survival of biologic therapies in psoriasis patients (vol 45, pg 813, 2020)Correction000567548600001II33310.1080/09546634.2020.1816609